Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BF4RFH31
Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
Issuer | Blackrock |
Entity holding fund | iShares III Public Limited Company |
Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
Entity LEI | 549300PZLRJB7M8H1057 |
ETF Ticker | WSML(USD) LSE |
ETF Ticker | WLDS(GBP) LSE |
ETF Ticker | IUSN(EUR) F |
ETF Ticker | IUSN.DE(EUR) CXE |
ETF Ticker | WLDS.LS(GBP) CXE |
ETF Ticker | WSML.LS(USD) CXE |
ETF Ticker | WSML.L(GBP) LSE |
ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for BIO
Stock Name | Bio-Rad Laboratories Inc |
Ticker | BIO(USD) NYSE |
TYPE | Common Stock |
Country | USA |
ISIN | US0905722072 |
LEI | 549300ZC1GPV35XYDK53 |
Ticker | BIO(EUR) F |
Show aggregate BIO holdings
News associated with BIO
- IYH's Holdings Imply 20% Gain Potential
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:57:22
- Fund Update: First Pacific Advisors, LP Just Disclosed New Holdings
- First Pacific Advisors, LP just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 03-31-2025 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-05-06 15:40:06
- Analysts Predict 16% Gains Ahead For The Holdings of PBUS
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-05 08:54:32
- Sum Up The Pieces: USXF Could Be Worth $60
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-04 10:12:16
- Is Thermo Fisher Scientific Stock Underperforming the S&P 500?
- Although Thermo Fisher Scientific has lagged behind the broader S&P 500 index over the past year, analysts remain confident in its long-term growth prospects. - 2025-03-03 12:36:56
iShares MSCI World Small Cap UCITS ETF USD (Acc) BIO holdings
Date | Number of BIO Shares Held | Base Market Value of BIO Shares | Local Market Value of BIO Shares | Change in BIO Shares Held | Change in BIO Base Value | Current Price per BIO Share Held | Previous Price per BIO Share Held |
---|
2025-10-15 (Wednesday) | 12,648 | USD 3,868,391 | USD 3,868,391 | | | | |
2025-10-10 (Friday) | 12,573 | USD 3,743,234 | USD 3,743,234 | | | | |
2025-10-08 (Wednesday) | 12,573 | USD 3,807,482 | USD 3,807,482 | | | | |
2025-10-07 (Tuesday) | 12,573 | USD 3,728,146 | USD 3,728,146 | 50 | USD -143,590 | USD 296.52 | USD 309.17 |
2025-10-06 (Monday) | 12,523 | USD 3,871,736 | USD 3,871,736 | 0 | USD 46,085 | USD 309.17 | USD 305.49 |
2025-10-03 (Friday) | 12,523 | USD 3,825,651 | USD 3,825,651 | 0 | USD 140,883 | USD 305.49 | USD 294.24 |
2025-10-02 (Thursday) | 12,523 | USD 3,684,768 | USD 3,684,768 | 0 | USD -46,460 | USD 294.24 | USD 297.95 |
2025-10-01 (Wednesday) | 12,523 | USD 3,731,228 | USD 3,731,228 | 0 | USD 219,904 | USD 297.95 | USD 280.39 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of BIO by Blackrock for IE00BF4RFH31
Show aggregate share trades of BIODate | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
---|
2025-10-07 | BUY | 50 | | | 296.520* | | 251.15 |
2025-09-08 | SELL | -100 | | | 290.380* | | 241.74 Profit of 24,174 on sale |
2025-08-15 | BUY | 50 | | | 285.660* | | 240.45 |
2025-07-14 | BUY | 100 | | | 250.810* | | 235.71 |
2025-06-30 | BUY | 100 | | | 241.320* | | 229.70 |
2025-06-25 | BUY | 150 | | | 240.980* | | 228.23 |
2025-06-23 | BUY | 1,159 | | | 235.540* | | 227.09 |
2025-06-20 | SELL | -23 | | | 236.740* | | 226.41 Profit of 5,207 on sale |
2025-06-12 | SELL | -184 | | | 232.420* | | 223.02 Profit of 41,036 on sale |
2025-06-02 | BUY | 69 | | | 216.560* | | 0.00 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of BIO
Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
---|
2025-09-19 | 56,212 | 0 | 69,401 | 81.0% |
2025-09-18 | 63,664 | 0 | 72,807 | 87.4% |
2025-09-17 | 84,169 | 0 | 109,098 | 77.1% |
2025-09-16 | 45,693 | 0 | 70,723 | 64.6% |
2025-09-15 | 64,227 | 196 | 87,925 | 73.0% |
2025-09-12 | 89,112 | 0 | 109,382 | 81.5% |
2025-09-11 | 55,025 | 0 | 71,905 | 76.5% |
2025-09-10 | 69,114 | 0 | 82,707 | 83.6% |
2025-09-09 | 61,864 | 0 | 78,931 | 78.4% |
2025-09-08 | 67,280 | 9,433 | 82,450 | 81.6% |
2025-09-05 | 98,316 | 482 | 116,028 | 84.7% |
2025-09-04 | 52,044 | 0 | 64,541 | 80.6% |
2025-09-03 | 57,268 | 0 | 74,609 | 76.8% |
2025-09-02 | 73,582 | 15,480 | 81,347 | 90.5% |
2025-08-29 | 76,655 | 0 | 86,900 | 88.2% |
2025-08-28 | 72,525 | 0 | 90,068 | 80.5% |
2025-08-27 | 70,650 | 3 | 87,624 | 80.6% |
2025-08-26 | 52,514 | 0 | 69,991 | 75.0% |
2025-08-25 | 49,107 | 0 | 58,909 | 83.4% |
2025-08-22 | 345,453 | 0 | 394,596 | 87.5% |
2025-08-21 | 43,382 | 0 | 55,927 | 77.6% |
2025-08-20 | 43,270 | 0 | 53,972 | 80.2% |
2025-08-19 | 30,612 | 5 | 51,808 | 59.1% |
2025-08-18 | 35,855 | 0 | 57,240 | 62.6% |
2025-08-15 | 41,260 | 0 | 56,036 | 73.6% |
2025-08-14 | 41,462 | 15 | 51,724 | 80.2% |
2025-08-13 | 65,793 | 0 | 78,398 | 83.9% |
2025-08-12 | 79,063 | 0 | 97,072 | 81.4% |
2025-08-11 | 53,269 | 0 | 70,729 | 75.3% |
2025-08-08 | 51,553 | 0 | 81,569 | 63.2% |
2025-08-07 | 68,500 | 0 | 84,930 | 80.7% |
2025-08-06 | 90,035 | 3 | 133,811 | 67.3% |
2025-08-05 | 78,757 | 0 | 142,743 | 55.2% |
2025-08-04 | 163,236 | 0 | 215,363 | 75.8% |
2025-08-01 | 310,265 | 0 | 481,010 | 64.5% |
2025-07-31 | 95,522 | 13 | 136,116 | 70.2% |
2025-07-30 | 57,986 | 0 | 161,476 | 35.9% |
2025-07-29 | 49,274 | 29 | 93,156 | 52.9% |
2025-07-28 | 59,137 | 0 | 108,883 | 54.3% |
2025-07-25 | 69,773 | 0 | 99,949 | 69.8% |
2025-07-24 | 36,374 | 0 | 63,640 | 57.2% |
2025-07-23 | 87,728 | 0 | 114,357 | 76.7% |
2025-07-22 | 94,241 | 0 | 187,504 | 50.3% |
2025-07-21 | 67,414 | 0 | 77,981 | 86.4% |
2025-07-18 | 60,540 | 0 | 86,947 | 69.6% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.